Loading provider…
Loading provider…
Pediatrics Physician in West Columbia, SC
NPI: 1457328932Primary Practice Location
Intramed Plus Infusion & Medical Center, Inc.
112 Saluda Ridge Ct, West Columbia, SC
Primary Employer
Intramed Plus Infusion & Medical Center, Inc.
intramedplus.com
HQ Phone
Get MD Ronnie's Phone Numberphone_androidMobile
Get MD Ronnie's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardSC State Medical License
SC State Medical License
1984 - 2025
AR State Medical License
1982 - 1985

American Board of Pediatrics
Pediatrics

American Board of Pediatrics
Pediatric Hematology-Oncology
Jacobs School of Medicine and Biomedical Sciences
medicine.buffalo.edu
Medical School
Until 1977
1978 - 1980
1978 - 1980
SUNY Upstate Medical University
upstate.edu
1980 - 1982
1980 - 1982
St. Joseph's Hospital Health Center
1977 - 1978
1977 - 1978
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 96372Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | 279 | 950 |
| 2 | J0897Injection, denosumab, 1 mg | 260 | 24,000 |
| 3 | 99202New patient office or other outpatient visit, typically 20 minutes | 189 | 189 |
| 4 | 96365Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour | 127 | 871 |
| 5 | 96413Infusion of chemotherapy into a vein up to 1 hour | 38 | 110 |
Authors: Sridharan Gururangan, Timothy Driscoll, Giles Robinson, Gerald Grant
Journal: Pediatr Blood Cancer
Publication Date: 2015-05-04
Lead Sponsor: National Cancer Institute (NCI)
Intervention / Treatment: OTHER: Questionnaire Administration, OTHER: Laboratory Biomarker Analysis, OTHER: Pharmacological Study, OTHER: Quality-of-Life Assessment, DRUG: Cyclophosphamide, DRUG: Prednisone, DRUG: Brentuximab Vedotin, DRUG: Etoposide, DRUG: Vincristine Sulfate, DRUG: Methylprednisolone, BIOLOGICAL: Bleomycin Sulfate, DRUG: Doxorubicin Hydrochloride
Lead Sponsor: National Cancer Institute (NCI)
Intervention / Treatment: RADIATION: Stereotactic Radiosurgery, RADIATION: External Beam Radiation Therapy, DRUG: Doxorubicin, DRUG: Cyclophosphamide, DRUG: Ifosfamide, DRUG: Etoposide, DRUG: Vincristine Sulfate, DRUG: Vincristine, BIOLOGICAL: Ganitumab, DRUG: Doxorubicin Hydrochloride, PROCEDURE: Therapeutic Surgical Procedure, DRUG: Etoposide Phosphate
Lead Sponsor: National Cancer Institute (NCI)
Intervention / Treatment: DRUG: Doxorubicin, DRUG: Dexamethasone, RADIATION: Radiation Therapy, DRUG: Cyclophosphamide, DRUG: Cytarabine, DRUG: Ifosfamide, DRUG: Etoposide, DRUG: Bortezomib, DRUG: Vincristine Sulfate, DRUG: Methotrexate, DRUG: Vincristine, DRUG: Mercaptopurine, DRUG: Thioguanine, DRUG: Doxorubicin Hydrochloride, DRUG: Daunorubicin, DRUG: Pegaspargase, DRUG: Leucovorin Calcium, DRUG: Daunorubicin Hydrochloride, DRUG: Hydrocortisone Sodium Succinate